Increased uptake of biologics in historically small molecule blockbuster-dominated therapeutic areas

Author： Emerton Duncan A N   Belsey Mark J  

Publisher： Palgrave Macmillan Ltd

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.13, Iss.1, 2006-10, pp. : 48-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identifying apoptotic cells with the 3-hydroxyflavone derivative F2N12S, a ratiometric fluorescent small molecule probe selective for plasma membranes: a possible general mechanism for selective uptake into apoptotic cells

By Hope-Roberts M   Horobin RW   Wainwright M  

Biotechnic & Histochemistry, Vol. 86, Iss. 4, 2011-08 ,pp. : 255-261

Informa Healthcare

Access to resources Recommend Favorite

Small-molecule metabolism: an enzyme mosaic

By Teichmann S.A.   Rison S.C.G.   Thornton J.M.   Riley M.   Gough J.   Chothia C.  

Trends in Biotechnology, Vol. 19, Iss. 12, 2001-12 ,pp. : 482-486

Elsevier

Access to resources Recommend Favorite

Biotech blockbuster forecasts to 2008

By Pavlou Alex K   Belsey Mark  

Journal of Commercial Biotechnology, Vol. 11, Iss. 1, 2004-10 ,pp. : 80-86

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Editorial: De-risking novel therapeutic development – time to stop blaming the molecule?

By Shohet Simon  

Journal of Commercial Biotechnology, Vol. 12, Iss. 1, 2005-10 ,pp. : 5-7

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Identifying small-molecule lead compounds: the screening approach to drug discovery

By Bevan P.   Ryder H.   Shaw I.  

Trends in Biotechnology, Vol. 13, Iss. 3, 1995-03 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite